Alethia Young

CIK 1918147 · Chief Financial Officer · last filed 2026-01-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.22M

Companies

4

Total Filings

18

Lifetime Open-Market Net

-$542.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCYC Chief Financial Officer 91,415 $4.05 $370.2K -$77.4K 7 2026-01-06
PTCT Director 21,067 $75.14 $1.58M -$465.0K 6 2026-01-06
PCRX Director 11,393 $22.99 $261.9K $0 3 2025-06-13
LENZ Therapeutics, Inc. (GRPH) Delisted Chief Financial Officer $22.26 $0 2 2023-02-23

Recent Filings · Page 2 of 2

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-01-04 BCYC Grant (A) +12,000 $0 EDGAR
2023-10-11 PCRX Grant (A) $0 EDGAR
2023-09-08 PTCT Mixed -$140.1K EDGAR
2023-07-19 BCYC Grant (A) $0 EDGAR
2023-02-23 LENZ Therapeutics, Inc. (GRPH) Delisted Grant (A) $0 EDGAR
2023-01-09 PTCT Grant (A) +4,000 $0 EDGAR
2022-06-10 PTCT Grant (A) +5,067 $0 EDGAR
2022-04-05 LENZ Therapeutics, Inc. (GRPH) Delisted Grant (A) $0 EDGAR
Showing 1118 of 18
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.